Galderma Group AG
Galderma Group AG, a leading player in the pharmaceutical preparation manufacturing industry, is headquartered in Switzerland (CH). Founded in 1981, the company has established itself as a pioneer in dermatology and aesthetic medicine, focusing on innovative solutions for skin health. With a strong presence in Europe, North America, and Asia, Galderma is renowned for its diverse portfolio, which includes products like Restylane and Dysport, designed to enhance skin appearance and treat various dermatological conditions.
Galderma's commitment to research and development has led to significant milestones, positioning it as a trusted name in the market. The company's unique formulations and dedication to safety and efficacy have garnered numerous accolades, solidifying its reputation as a leader in skin care and aesthetic treatments.
-13 vs industry average
Galderma Group AG’s score of 27 is lower than 41% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Galderma Group AG?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2026
Reported emissions
Scope 3 accounts for ••• of total emissions.
Galderma Group AG's reported carbon emissions
Galderma Group AG, a pharmaceutical preparation manufacturing company headquartered in Switzerland (CH), has reported its carbon emissions for recent years.
For the year 2023, Galderma's total carbon emissions were approximately 345.3 million kg CO2e. This total encompasses Scope 1, Scope 2, and Scope 3 emissions. Specifically, Scope 1 emissions accounted for about 7.6 million kg CO2e, while Scope 2 emissions were approximately 5.5 million kg CO2e (location-based). Scope 3 emissions represented the largest portion, totalling around 332.1 million kg CO2e. It is noted that data for Scope 3 purchased goods and services was missing for this reporting year.
In 2022, Galderma's total carbon emissions were approximately 351.1 million kg CO2e. Scope 1 emissions for 2022 were around 9.8 million kg CO2e. Scope 2 emissions, on a location-based basis, were approximately 5.6 million kg CO2e, with market-based Scope 2 emissions at about 4.2 million kg CO2e. Similar to 2023, Scope 3 emissions were substantial, totalling approximately 332.1 million kg CO2e, and purchased goods and services data was also noted as missing for this scope.
Galderma Group AG has not specified any document or SBTi reduction targets, nor is it currently a signatory to the Climate Pledge. The company's emissions data is not cascaded from a parent organisation, and its reporting is attributed directly to Galderma Group AG.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Galderma Group AG’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Galderma Group AG yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Galderma Group AG
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project